Free Trial

Mediolanum International Funds Ltd Trims Stock Holdings in Nutrien Ltd. (NYSE:NTR)

Nutrien logo with Basic Materials background

Mediolanum International Funds Ltd lessened its position in shares of Nutrien Ltd. (NYSE:NTR - Free Report) by 43.2% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 80,001 shares of the company's stock after selling 60,930 shares during the period. Mediolanum International Funds Ltd's holdings in Nutrien were worth $3,863,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently bought and sold shares of the company. Aviance Capital Partners LLC boosted its position in shares of Nutrien by 4.7% during the 1st quarter. Aviance Capital Partners LLC now owns 13,900 shares of the company's stock valued at $755,000 after acquiring an additional 618 shares during the last quarter. Dixon Mitchell Investment Counsel Inc. lifted its position in Nutrien by 5.6% during the first quarter. Dixon Mitchell Investment Counsel Inc. now owns 165,902 shares of the company's stock valued at $9,108,000 after purchasing an additional 8,758 shares during the last quarter. Maryland State Retirement & Pension System grew its stake in Nutrien by 23.2% in the 1st quarter. Maryland State Retirement & Pension System now owns 50,899 shares of the company's stock worth $2,630,000 after buying an additional 9,589 shares in the last quarter. Principal Financial Group Inc. increased its holdings in shares of Nutrien by 1,244.0% in the 1st quarter. Principal Financial Group Inc. now owns 194,880 shares of the company's stock worth $10,598,000 after buying an additional 180,380 shares during the last quarter. Finally, Thomist Capital Management LP purchased a new stake in shares of Nutrien during the 1st quarter valued at $1,982,000. 63.10% of the stock is owned by institutional investors.

Nutrien Trading Up 0.2 %

NYSE:NTR traded up $0.09 during mid-day trading on Friday, reaching $47.89. 1,935,985 shares of the company's stock traded hands, compared to its average volume of 1,942,025. Nutrien Ltd. has a 12-month low of $44.65 and a 12-month high of $60.87. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.26 and a quick ratio of 0.82. The company has a 50 day moving average price of $47.79 and a 200-day moving average price of $50.88. The firm has a market capitalization of $23.69 billion, a price-to-earnings ratio of 28.01, a PEG ratio of 1.56 and a beta of 0.82.

Nutrien (NYSE:NTR - Get Free Report) last announced its earnings results on Wednesday, August 7th. The company reported $2.34 EPS for the quarter, beating analysts' consensus estimates of $2.19 by $0.15. The company had revenue of $10.16 billion during the quarter, compared to the consensus estimate of $10.82 billion. Nutrien had a return on equity of 6.91% and a net margin of 2.97%. The firm's revenue for the quarter was down 12.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.53 earnings per share. On average, sell-side analysts predict that Nutrien Ltd. will post 3.85 earnings per share for the current year.

Nutrien Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, October 18th. Stockholders of record on Friday, September 27th were given a $0.54 dividend. The ex-dividend date of this dividend was Friday, September 27th. This represents a $2.16 annualized dividend and a dividend yield of 4.51%. Nutrien's dividend payout ratio is 126.32%.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the stock. Barclays cut their target price on shares of Nutrien from $68.00 to $55.00 and set an "overweight" rating for the company in a research report on Friday, August 16th. Mizuho reduced their price objective on Nutrien from $55.00 to $52.00 and set a "neutral" rating on the stock in a research report on Thursday, August 8th. Royal Bank of Canada reissued an "outperform" rating and set a $60.00 price objective on shares of Nutrien in a report on Friday, September 20th. The Goldman Sachs Group lowered Nutrien from a "buy" rating to a "neutral" rating and cut their target price for the stock from $69.00 to $53.00 in a research note on Tuesday, September 10th. Finally, BMO Capital Markets reduced their price target on shares of Nutrien from $80.00 to $75.00 and set an "outperform" rating on the stock in a research report on Friday, August 9th. Three investment analysts have rated the stock with a sell rating, six have assigned a hold rating and ten have assigned a buy rating to the company. According to data from MarketBeat.com, Nutrien has an average rating of "Hold" and a consensus target price of $60.67.

Get Our Latest Stock Analysis on Nutrien

About Nutrien

(Free Report)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

See Also

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Should you invest $1,000 in Nutrien right now?

Before you consider Nutrien, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.

While Nutrien currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines